AtriCure Inc
ATRC35.090USD
+0.080+0.23%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
1.74BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über AtriCure Inc Unternehmen
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Unternehmensinformationen
BörsenkürzelATRC
Name des UnternehmensAtriCure Inc
IPO-datumAug 05, 2005
CEOMr. Michael H. (Mike) Carrel, CPA
Anzahl der mitarbeiter1300
WertpapierartOrdinary Share
GeschäftsjahresendeAug 05
Addresse7555 Innovation Way
StadtMASON
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl45040
Telefon15137554100
Websitehttps://www.atricure.com
BörsenkürzelATRC
IPO-datumAug 05, 2005
CEOMr. Michael H. (Mike) Carrel, CPA
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-6.78%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
Andere
12.28M
9.94%
Nach RegionUSD
Name
Umsatz
Anteil
United States
101.15M
81.82%
Europe
14.20M
11.49%
Asia
6.78M
5.49%
Other international
1.49M
1.20%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
Andere
12.28M
9.94%
Aktionärsstatistik
Aktualisiert: Sat, Aug 16
Aktualisiert: Sat, Aug 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.85%
Wellington Management Company, LLP
7.99%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.94%
Hood River Capital Management LLC
6.16%
Andere
61.88%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.85%
Wellington Management Company, LLP
7.99%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.94%
Hood River Capital Management LLC
6.16%
Andere
61.88%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.33%
Investment Advisor/Hedge Fund
39.16%
Hedge Fund
5.88%
Individual Investor
3.50%
Research Firm
1.63%
Pension Fund
0.81%
Bank and Trust
0.65%
Family Office
0.07%
Venture Capital
0.04%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
533
52.65M
105.93%
-5.83M
2025Q1
544
53.44M
107.95%
-4.07M
2024Q4
526
50.00M
102.31%
-11.07M
2024Q3
522
53.78M
110.47%
-8.64M
2024Q2
511
54.11M
111.85%
-4.03M
2024Q1
517
53.02M
109.65%
-1.47M
2023Q4
515
50.20M
105.93%
-1.70M
2023Q3
504
48.87M
103.22%
-3.82M
2023Q2
499
48.88M
103.48%
-3.46M
2023Q1
503
48.62M
102.63%
-1.48M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
4.70M
9.5%
+61.17K
+1.32%
Mar 31, 2025
AllianceBernstein L.P.
3.68M
7.43%
-158.60K
-4.14%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.57M
7.21%
-92.41K
-2.52%
Mar 31, 2025
Hood River Capital Management LLC
3.00M
6.06%
+75.48K
+2.58%
Mar 31, 2025
Macquarie Investment Management
2.44M
4.92%
+61.60K
+2.59%
Mar 31, 2025
Champlain Investment Partners, LLC
2.14M
4.32%
-390.65K
-15.45%
Mar 31, 2025
State Street Global Advisors (US)
1.28M
2.58%
-68.53K
-5.09%
Mar 31, 2025
Neuberger Berman, LLC
1.19M
2.4%
+246.88K
+26.29%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.17M
2.36%
+16.11K
+1.40%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
